<- Go Home
Theralink Technologies, Inc.
Theralink Technologies, Inc.develops and commercializes a series of data-generating assays, which provide an actionable information for physicians and patients, as well as biopharmaceutical companies in the areas of oncology. It enables physicians to help make personalized treatment recommendations for cancer patients. Theralink Technologies, Inc. was formerly known as Avant Diagnostics, Inc. The company was incorporated in 2005 and is based in Washington, District of Columbia.
Market Cap
$10.8M
Volume
43.9K
Cash and Equivalents
$62.2K
EBITDA
-$2.1M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
N/A
Profit Margin
N/A
52 Week High
$0.08
52 Week Low
$0.00
Dividend
N/A
Price / Book Value
5.83
Price / Earnings
-4.22
Price / Tangible Book Value
-3.83
Enterprise Value
N/A
Enterprise Value / EBITDA
N/A
Operating Income
-$2.5M
Return on Equity
193.31%
Return on Assets
-30.70
Cash and Short Term Investments
$62.2K
Debt
$56.3K
Equity
$1.9M
Revenue
N/A
Unlevered FCF
-$2.1M
Sector
Biotechnology
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium